Transcriptome Patterns of
Adult
Antineoplastic Combined Chemotherapy Protocols
/ therapeutic use
BRCA1 Protein
/ genetics
BRCA2 Protein
/ genetics
Breast Neoplasms
/ drug therapy
Computational Biology
/ methods
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Middle Aged
Mutation
Ovarian Neoplasms
/ drug therapy
Poly (ADP-Ribose) Polymerase-1
/ genetics
Poly(ADP-ribose) Polymerases
/ genetics
Survival Analysis
Transcriptome
Treatment Outcome
BRCA1
BRCA2
breast cancer
multi-layer self-organizing maps
ovarian cancer
somatic and germline mutations
transcriptome portrayal
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
28 Jan 2021
28 Jan 2021
Historique:
received:
17
12
2020
revised:
06
01
2021
accepted:
07
01
2021
entrez:
2
2
2021
pubmed:
3
2
2021
medline:
9
9
2021
Statut:
epublish
Résumé
Mutations in the
Identifiants
pubmed: 33525353
pii: ijms22031266
doi: 10.3390/ijms22031266
pmc: PMC7865215
pii:
doi:
Substances chimiques
BRCA1 Protein
0
BRCA1 protein, human
0
BRCA2 Protein
0
BRCA2 protein, human
0
PARP1 protein, human
EC 2.4.2.30
PARP2 protein, human
EC 2.4.2.30
Poly (ADP-Ribose) Polymerase-1
EC 2.4.2.30
Poly(ADP-ribose) Polymerases
EC 2.4.2.30
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Science Committee of the MESCS of Armenia
ID : 18RF-112
Organisme : Russian Foundation for Basic Research
ID : 18-515-05004
Références
BMC Bioinformatics. 2016 Dec 9;17(1):526
pubmed: 27938331
Nat Cancer. 2021 Jan;2(1):66-82
pubmed: 33738458
Am J Hum Genet. 2006 Feb;78(2):279-90
pubmed: 16358218
BMC Bioinformatics. 2011 Jul 27;12:306
pubmed: 21794127
Gynecol Oncol. 2011 May 1;121(2):353-7
pubmed: 21324516
Bioinformatics. 2015 Oct 1;31(19):3225-7
pubmed: 26063839
Nat Rev Cancer. 2010 Apr;10(4):293-301
pubmed: 20200537
Sci Rep. 2014 Feb 07;4:4026
pubmed: 24504028
J Ovarian Res. 2019 Mar 18;12(1):23
pubmed: 30885238
Cell Rep. 2018 Apr 17;23(3):918-929
pubmed: 29669295
Eur J Hum Genet. 2016 Sep;24 Suppl 1:S3-9
pubmed: 27514841
J Clin Oncol. 2012 Jul 20;30(21):2654-63
pubmed: 22711857
PeerJ. 2020 Jan 21;8:e8403
pubmed: 31998560
Cancer Discov. 2016 Sep;6(9):1052-67
pubmed: 27432226
Nature. 2012 Jan 18;481(7381):287-94
pubmed: 22258607
PLoS One. 2020 Sep 30;15(9):e0239197
pubmed: 32997669
Cancers (Basel). 2019 Jul 09;11(7):
pubmed: 31324052
Hered Cancer Clin Pract. 2006 Jan 15;4(1):28-38
pubmed: 20223001
Nat Biotechnol. 2010 Oct;28(10):1045-8
pubmed: 20944595
Medicines (Basel). 2018 Feb 01;5(1):
pubmed: 29389895
Pharmaceutics. 2019 Dec 12;11(12):
pubmed: 31842375
Clin Cancer Res. 2004 Apr 1;10(7):2473-81
pubmed: 15073127
Breast Cancer Res. 2004;6(4):R308-15
pubmed: 15217497
Cancers (Basel). 2020 Feb 08;12(2):
pubmed: 32046278
Endocr Relat Cancer. 2016 Jun;23(6):R267-85
pubmed: 27226207
N Engl J Med. 2007 Jul 12;357(2):115-23
pubmed: 17625123
J Cancer. 2018 Apr 6;9(8):1379-1384
pubmed: 29721047
BioData Min. 2012 Oct 08;5(1):18
pubmed: 23043905
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
Cancer Res. 2019 Jul 15;79(14):3608-3621
pubmed: 31118200
JAMA. 2012 Jan 25;307(4):382-90
pubmed: 22274685
J Clin Oncol. 2010 Aug 1;28(22):3570-6
pubmed: 20606085
Oncol Lett. 2019 Feb;17(2):1986-1995
pubmed: 30675265
Cancers (Basel). 2014 Apr 03;6(2):771-95
pubmed: 24704793
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
J Clin Oncol. 2012 Jan 1;30(1):19-26
pubmed: 22147742
Int J Cancer. 2004 Apr 20;109(4):525-32
pubmed: 14991573
Breast Cancer Res. 2017 Aug 25;19(1):99
pubmed: 28851423
Clin Breast Cancer. 2017 Jul;17(4):298-306.e7
pubmed: 28216417
Cancer Res. 2008 May 1;68(9):3108-14
pubmed: 18451135
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Mol Cell. 1999 Mar;3(3):389-95
pubmed: 10198641
Curr Biol. 1999 Oct 7;9(19):1107-10
pubmed: 10531007
J Natl Cancer Inst. 2002 Jul 3;94(13):990-1000
pubmed: 12096084
BMC Cancer. 2010 Mar 10;10:90
pubmed: 20219108
Cancer Prev Res (Phila). 2009 Feb;2(2):100-3
pubmed: 19174575
JAMA. 2011 Oct 12;306(14):1557-65
pubmed: 21990299
Clin Epidemiol. 2019 Jul 11;11:543-561
pubmed: 31372057
Eur J Cancer. 2016 Jun;60:49-58
pubmed: 27065456
Int J Mol Sci. 2020 Oct 12;21(20):
pubmed: 33053746
Front Oncol. 2013 Dec 20;3:301
pubmed: 24392349
Oncol Rep. 2014 Jan;31(1):365-9
pubmed: 24145998
Cancer Res. 2005 Nov 15;65(22):10265-72
pubmed: 16288014
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
J Exp Clin Cancer Res. 2019 Feb 19;38(1):89
pubmed: 30782177
BMC Cancer. 2020 Mar 12;20(1):197
pubmed: 32164626
Front Genet. 2016 Aug 09;7:147
pubmed: 27555866
Cancers (Basel). 2020 Feb 08;12(2):
pubmed: 32046300
Clin Cancer Res. 2015 Jan 1;21(1):211-20
pubmed: 25348513
Cancers (Basel). 2020 Jan 31;12(2):
pubmed: 32023849
Int J Cancer. 2007 Sep 1;121(5):1017-20
pubmed: 17471561
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
J Natl Cancer Inst. 2002 Jul 3;94(13):960-1
pubmed: 12096075
Cancer. 2012 Aug 1;118(15):3703-9
pubmed: 22139894
Cancer Med. 2020 Mar;9(6):2190-2200
pubmed: 31991061
Exp Cell Res. 2018 Feb 15;363(2):160-170
pubmed: 29305171
J Clin Oncol. 2013 Sep 10;31(26):3191-6
pubmed: 23940229
Nat Rev Cancer. 2011 Dec 23;12(1):68-78
pubmed: 22193408
Int J Clin Exp Pathol. 2020 May 01;13(5):944-953
pubmed: 32509065
PLoS One. 2017 Nov 3;12(11):e0187572
pubmed: 29099860
Curr Probl Cancer. 2011 Jan-Feb;35(1):7-50
pubmed: 21300207
Ann Oncol. 2013 Nov;24 Suppl 8:viii63-viii68
pubmed: 24131973
J Biol Chem. 2015 Jul 17;290(29):17724-17732
pubmed: 26048987
Front Genet. 2016 May 06;7:79
pubmed: 27200087
Clin Cancer Res. 2004 Mar 15;10(6):2029-34
pubmed: 15041722
BMC Genomics. 2005 Mar 11;6:37
pubmed: 15762987
Pharmacogenomics. 2012 Oct;13(13):1523-35
pubmed: 23057551
N Engl J Med. 2001 Feb 22;344(8):539-48
pubmed: 11207349